Masking Policies at National Cancer Institute-Designated Cancer Centers During Winter 2023 to 2024 COVID-19 Surge

Michael Hoerger; Dulcé Rivera; Brenna Mossman; Birney Sherard; Tristen Peyser; Taylor M Alcorn

doi:10.1001/jamanetworkopen.2024.24999

Masking Policies at National Cancer Institute-Designated Cancer Centers During Winter 2023 to 2024 COVID-19 Surge

JAMA Netw Open. 2024 Jul 1;7(7):e2424999. doi: 10.1001/jamanetworkopen.2024.24999.

Authors

Michael Hoerger^{1

2

3

4}, Dulcé Rivera^{1

2}, Brenna Mossman^{1

2}, Birney Sherard^{1

2}, Tristen Peyser^{1

2}, Taylor M Alcorn^{1

2}

Affiliations

¹ Tulane Cancer Center, Tulane University, New Orleans, Louisiana.
² Department of Psychology, Tulane University, New Orleans, Louisiana.
³ Department of Medicine (Hematology and Oncology), Tulane University, New Orleans, Louisiana.
⁴ Department of Palliative Medicine and Supportive Care, University Medical Center, New Orleans, Louisiana.

No abstract available

Plain language summary

This cross-sectional study examines variation in masking policies at National Cancer Institute (NCI)–designated cancer centers during the winter 2023-2024 COVID-19 surge.

MeSH terms

COVID-19* / epidemiology
Cancer Care Facilities* / organization & administration
Humans
Masks
National Cancer Institute (U.S.)*
Neoplasms
Pandemics
SARS-CoV-2*
Seasons
United States / epidemiology